美国食品药品监督管理局的关键路径计划：简要介绍。 - Suppr

Suppr

超能文献

The FDA's critical path initiative: a brief introduction.

作者信息

Coons Stephen Joel

出版信息

Clin Ther. 2009 Nov;31(11):2572-3. doi: 10.1016/j.clinthera.2009.11.035.

DOI:10.1016/j.clinthera.2009.11.035

PMID:20110002

Abstract

摘要

相似文献

The FDA's critical path initiative: a brief introduction.

Clin Ther. 2009 Nov;31(11):2572-3. doi: 10.1016/j.clinthera.2009.11.035.

FDA's role in drug product recalls.

Am J Hosp Pharm. 1991 Dec;48(12):2595-6.

Raising the bar for market authorisation of new drugs.

BMJ. 2012 Aug 7;345:e4261. doi: 10.1136/bmj.e4261.

The FDA's restrictions against prescription drug advertising: more hindrance than help.

Healthspan. 1991 Nov;8(10):3-7.

FDA's regulation of prescription drug labeling: a role for implied preemption.

Food Drug Law J. 2007;62(1):227-47.

FDA's interferon-beta decision reignites orphan debate.

Nat Biotechnol. 1999 Apr;17(4):324-5. doi: 10.1038/7875.

Presumption of innocence: FDA's authority to regulate the specifics of prescription drug labeling and the preemption debate.

Food Drug Law J. 2006;61(4):585-622.

Incentives for drug development--the curious case of colchicine.

N Engl J Med. 2010 Jun 3;362(22):2045-7. doi: 10.1056/NEJMp1003126. Epub 2010 Apr 14.

Update of FDA's Critical Path Initiative.

Clin Adv Hematol Oncol. 2009 Mar;7(3):173-4.

Prescription for the Orphan Drug Act: the impact of the FDA's 1992 regulations and the latest congressional proposals for reform.

Food Drug Law J. 1995;50(1):125-47.

引用本文的文献

Tenofovir disoproxil fumarate initiation and changes in urinary biomarker concentrations among HIV-infected men and women.

AIDS. 2019 Mar 15;33(4):723-733. doi: 10.1097/QAD.0000000000002114.

High intensity resistance training causes muscle damage and increases biomarkers of acute kidney injury in healthy individuals.

PLoS One. 2018 Nov 6;13(11):e0205791. doi: 10.1371/journal.pone.0205791. eCollection 2018.

Urine Trefoil Factors as Prognostic Biomarkers in Chronic Kidney Disease.

Biomed Res Int. 2018 Apr 3;2018:3024698. doi: 10.1155/2018/3024698. eCollection 2018.

Increased trefoil factor 2 levels in patients with chronic kidney disease.

PLoS One. 2017 Mar 29;12(3):e0174551. doi: 10.1371/journal.pone.0174551. eCollection 2017.

Trefoil Factor 1 Excretion Is Increased in Early Stages of Chronic Kidney Disease.

PLoS One. 2015 Sep 21;10(9):e0138312. doi: 10.1371/journal.pone.0138312. eCollection 2015.

Use of Bayesian multivariate meta-analysis to estimate the HAQ for mapping onto the EQ-5D questionnaire in rheumatoid arthritis.

Value Health. 2014 Jan-Feb;17(1):109-15. doi: 10.1016/j.jval.2013.11.005.

Analysis of a urinary biomarker panel for incident kidney disease and clinical outcomes.

J Am Soc Nephrol. 2013 Nov;24(11):1880-8. doi: 10.1681/ASN.2013010019. Epub 2013 Aug 29.

Future detection and monitoring of diabetes may entail analysis of both β-cell function and volume: how markers of β-cell loss may assist.

J Transl Med. 2012 Oct 30;10:214. doi: 10.1186/1479-5876-10-214.

Trefoil factor 3 predicts incident chronic kidney disease: a case-control study nested within the Atherosclerosis Risk in Communities (ARIC) study.

Am J Nephrol. 2011;34(4):291-7. doi: 10.1159/000330699. Epub 2011 Aug 9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验